Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Astrocytes display ultrastructural alterations and heterogeneity in the hippocampus of aged APP-PS1 mice and human post-mortem brain samples.

Tytuł:
Astrocytes display ultrastructural alterations and heterogeneity in the hippocampus of aged APP-PS1 mice and human post-mortem brain samples.
Autorzy:
St-Pierre MK; Axe Neurosciences, Centre de Recherche du CHU de Québec-Université Laval, Québec, QC, Canada.; Départment de Médecine Moléculaire, Faculté de Médecine, Université Laval, Québec, QC, Canada.; Division of Medical Sciences, Medical Sciences Building, University of Victoria, Victoria, BC, Canada.
Carrier M; Axe Neurosciences, Centre de Recherche du CHU de Québec-Université Laval, Québec, QC, Canada.; Division of Medical Sciences, Medical Sciences Building, University of Victoria, Victoria, BC, Canada.
González Ibáñez F; Axe Neurosciences, Centre de Recherche du CHU de Québec-Université Laval, Québec, QC, Canada.; Départment de Médecine Moléculaire, Faculté de Médecine, Université Laval, Québec, QC, Canada.; Division of Medical Sciences, Medical Sciences Building, University of Victoria, Victoria, BC, Canada.
Khakpour M; Division of Medical Sciences, Medical Sciences Building, University of Victoria, Victoria, BC, Canada.
Wallman MJ; Département de Psychiatrie et de Neurosciences, Faculté de Médecine, Université Laval, Québec, QC, Canada.; CERVO Brain Research Center, Quebec City, QC, Canada.
Parent M; Département de Psychiatrie et de Neurosciences, Faculté de Médecine, Université Laval, Québec, QC, Canada.; CERVO Brain Research Center, Quebec City, QC, Canada.
Tremblay MÈ; Axe Neurosciences, Centre de Recherche du CHU de Québec-Université Laval, Québec, QC, Canada. .; Départment de Médecine Moléculaire, Faculté de Médecine, Université Laval, Québec, QC, Canada. .; Division of Medical Sciences, Medical Sciences Building, University of Victoria, Victoria, BC, Canada. .; Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC, Canada. .; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada. .; Centre for Advanced Materials and Related Technology (CAMTEC), University of Victoria, Victoria, BC, Canada. .; Institute on Aging and Lifelong Health, University of Victoria, Victoria, BC, Canada. .
Źródło:
Journal of neuroinflammation [J Neuroinflammation] 2023 Mar 14; Vol. 20 (1), pp. 73. Date of Electronic Publication: 2023 Mar 14.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: [London] : BioMed Central, c2004-
MeSH Terms:
Astrocytes*/metabolism
Alzheimer Disease*/pathology
Mice ; Humans ; Male ; Animals ; Aged ; Infant ; Mice, Inbred C57BL ; Brain/metabolism ; Hippocampus/metabolism ; Mice, Transgenic ; Disease Models, Animal ; Amyloid beta-Protein Precursor/genetics ; Amyloid beta-Protein Precursor/metabolism ; Presenilin-1/genetics ; Presenilin-1/metabolism
References:
Folia Neuropathol. 2015;53(3):173-92. (PMID: 26443309)
Ann Neurol. 1991 Oct;30(4):572-80. (PMID: 1789684)
Pflugers Arch. 2019 Oct;471(10):1247-1261. (PMID: 31520182)
EMBO Mol Med. 2020 Mar 6;12(3):e10606. (PMID: 31951107)
J Alzheimers Dis Parkinsonism. 2018;8(1):. (PMID: 29928558)
Mol Brain. 2021 Jul 10;14(1):111. (PMID: 34246283)
PLoS Med. 2018 Jan 25;15(1):e1002482. (PMID: 29370177)
Genome Res. 2021 Oct;31(10):1900-1912. (PMID: 33627474)
Front Neuroanat. 2018 Feb 14;12:8. (PMID: 29497365)
Neurosci Res. 2021 May;166:62-72. (PMID: 32512031)
J Neurosci. 1996 Feb 1;16(3):877-85. (PMID: 8558256)
Physiol Rev. 2018 Jan 1;98(1):239-389. (PMID: 29351512)
Cells. 2020 Nov 04;9(11):. (PMID: 33158189)
J Vis Exp. 2016 Jun 01;(112):. (PMID: 27286292)
Cell. 2017 Jun 15;169(7):1276-1290.e17. (PMID: 28602351)
F1000Res. 2020 Apr 2;9:. (PMID: 32269761)
Sci Transl Med. 2017 May 31;9(392):. (PMID: 28566429)
Neurobiol Aging. 2021 Oct;106:207-222. (PMID: 34303222)
Sci Rep. 2018 Jan 10;8(1):350. (PMID: 29321618)
Methods Mol Biol. 2019;2034:97-110. (PMID: 31392680)
Front Pharmacol. 2022 Oct 03;13:1039904. (PMID: 36263143)
Neurobiol Aging. 1991 Sep-Oct;12(5):593-600. (PMID: 1770990)
J Neurosci. 2020 Aug 19;40(34):6503-6521. (PMID: 32661024)
Stroke. 1998 Apr;29(4):859-65. (PMID: 9550523)
Front Cell Dev Biol. 2021 Feb 18;9:629503. (PMID: 33681208)
Neuron. 2010 Jan 14;65(1):7-19. (PMID: 20152109)
Metab Brain Dis. 2022 Jan;37(1):39-50. (PMID: 34406560)
J Neurocytol. 1986 Jun;15(3):273-90. (PMID: 3528398)
Neuron. 2004 Feb 5;41(3):405-15. (PMID: 14766179)
Acta Neuropathol. 1985;67(1-2):6-12. (PMID: 4040695)
Brain Behav Immun. 2018 Oct;73:450-469. (PMID: 29908963)
Exp Neurol. 1999 Jul;158(1):221-8. (PMID: 10448435)
Cell Rep. 2019 Apr 23;27(4):1293-1306.e6. (PMID: 31018141)
Acta Neuropathol. 2008 Oct;116(4):447-52. (PMID: 18521615)
Glia. 2020 Nov;68(11):2361-2376. (PMID: 32469469)
Life Sci Alliance. 2021 Jun 14;4(7):. (PMID: 34127518)
Proc Natl Acad Sci U S A. 2021 Dec 28;118(52):. (PMID: 34949639)
Glia. 2021 Apr;69(4):997-1011. (PMID: 33283891)
Front Cell Neurosci. 2022 Aug 12;16:932572. (PMID: 36035256)
J Neuroinflammation. 2021 Mar 17;18(1):73. (PMID: 33731156)
ASN Neuro. 2020 Jan-Dec;12:1759091420925335. (PMID: 32443939)
Science. 2001 Jan 26;291(5504):657-61. (PMID: 11158678)
Brain Behav Immun. 2020 Nov;90:81-96. (PMID: 32755645)
Cell Rep. 2019 Aug 20;28(8):2111-2123.e6. (PMID: 31433986)
Cell Death Dis. 2021 Oct 16;12(11):954. (PMID: 34657143)
PLoS One. 2020 Aug 21;15(8):e0238104. (PMID: 32822415)
J Neuroinflammation. 2020 Apr 2;17(1):98. (PMID: 32241286)
Glia. 2021 Jun;69(6):1540-1562. (PMID: 33609060)
Neurosci Biobehav Rev. 2020 Nov;118:331-357. (PMID: 32768488)
Brain Commun. 2020 Dec 19;3(1):fcaa219. (PMID: 33615215)
Cereb Cortex. 2020 Apr 14;30(4):2114-2127. (PMID: 31807747)
Acta Neuropathol. 2000 Oct;100(4):356-64. (PMID: 10985692)
FEBS Open Bio. 2021 Jan;11(1):146-163. (PMID: 33185010)
Front Cell Neurosci. 2018 Nov 14;12:421. (PMID: 30487735)
Neurodegener Dis. 2019;19(3-4):109-127. (PMID: 32062666)
Immunity. 2017 Sep 19;47(3):566-581.e9. (PMID: 28930663)
IEEE Trans Vis Comput Graph. 2018 Jan;24(1):853-861. (PMID: 28866534)
Cereb Cortex. 2003 Dec;13(12):1344-51. (PMID: 14615299)
Cell Metab. 2020 Mar 3;31(3):503-517.e8. (PMID: 32130882)
CNS Neurosci Ther. 2019 Jun;25(6):665-673. (PMID: 30929313)
Cell Commun Adhes. 2003 Jul-Dec;10(4-6):401-6. (PMID: 14681048)
Acta Neuropathol. 2019 Nov;138(5):729-749. (PMID: 31392412)
Ageing Res Rev. 2016 Sep;30:25-48. (PMID: 26827786)
Neuron. 2014 May 21;82(4):756-71. (PMID: 24853936)
Nat Neurosci. 2020 Feb;23(2):194-208. (PMID: 31959936)
Mol Psychiatry. 2021 Jul;26(7):2740-2752. (PMID: 33879866)
Expert Rev Neurother. 2010 Nov;10(11):1667-73. (PMID: 20977325)
Commun Integr Biol. 2016 Oct 3;9(6):e1230575. (PMID: 28042375)
Cell Rep. 2021 Jun 8;35(10):109228. (PMID: 34107254)
Acta Neuropathol Commun. 2021 Jun 8;9(1):108. (PMID: 34103079)
iScience. 2020 May 6;23(5):101136. (PMID: 32446205)
Acta Neuropathol. 2022 Jan;143(1):75-91. (PMID: 34767070)
J Int Med Res. 2019 Oct;47(10):5019-5027. (PMID: 31524019)
Nature. 2004 Sep 9;431(7005):195-9. (PMID: 15356633)
Mol Neurodegener. 2021 Mar 22;16(1):18. (PMID: 33752701)
Mol Neurodegener. 2020 Nov 10;15(1):66. (PMID: 33168021)
J Comp Neurol. 2016 Jan 1;524(1):23-38. (PMID: 26179415)
Nat Genet. 2021 Aug;53(8):1143-1155. (PMID: 34239132)
J Neuroinflammation. 2018 Sep 6;15(1):256. (PMID: 30189875)
J Neurosci. 2016 Jan 13;36(2):577-89. (PMID: 26758846)
Neurobiology (Bp). 1994;2(3):245-53. (PMID: 7881403)
Neuron. 1997 Oct;19(4):939-45. (PMID: 9354339)
Brain Inj. 1999 Apr;13(4):291-304. (PMID: 10230530)
Neuroreport. 2008 Mar 26;19(5):543-7. (PMID: 18388735)
Sci Rep. 2021 Oct 15;11(1):20511. (PMID: 34654853)
Neurosci Lett. 2003 Mar 27;339(3):183-6. (PMID: 12633883)
Glia. 2018 Jun;66(6):1244-1262. (PMID: 29076603)
Glia. 2016 May;64(5):826-39. (PMID: 26847266)
Glia. 2007 Sep;55(12):1251-1262. (PMID: 17659524)
Curr Opin Cell Biol. 2015 Feb;32:121-30. (PMID: 25726916)
Glia. 2020 May;68(5):1017-1030. (PMID: 31799735)
J Alzheimers Dis. 2018;61(1):415-424. (PMID: 29171994)
Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):8093-7. (PMID: 10869421)
J Clin Invest. 2013 Mar;123(3):1299-309. (PMID: 23434588)
J Neuroinflammation. 2020 Sep 5;17(1):264. (PMID: 32891154)
Front Cell Neurosci. 2015 Mar 20;9:76. (PMID: 25852472)
Brain Behav Immun Health. 2021 Jun 09;15:100281. (PMID: 34589781)
J Neuroinflammation. 2022 Feb 2;19(1):30. (PMID: 35109872)
Nat Commun. 2021 May 27;12(1):3190. (PMID: 34045465)
Methods Mol Biol. 2022;2515:29-58. (PMID: 35776344)
Neurosurgery. 1996 Mar;38(3):533-41; discussion 541. (PMID: 8837806)
Nature. 2015 Jul 16;523(7560):337-41. (PMID: 26030524)
Cold Spring Harb Perspect Biol. 2015 Feb 06;7(9):a020370. (PMID: 25663667)
Front Cell Neurosci. 2021 Jun 29;15:701673. (PMID: 34267628)
Eur Arch Psychiatry Clin Neurosci. 2020 Jun;270(4):483-488. (PMID: 31218445)
Trends Neurosci. 2020 Jul;43(7):458-466. (PMID: 32423764)
Cell. 2019 May 30;177(6):1522-1535.e14. (PMID: 31130380)
J Mol Psychiatry. 2013 Oct 24;1:18. (PMID: 26019866)
Alzheimers Dement. 2017 Sep;13(9):965-984. (PMID: 28341160)
Front Cell Neurosci. 2019 Mar 06;13:82. (PMID: 30894801)
Methods Mol Biol. 2019;2034:83-95. (PMID: 31392679)
Nat Neurosci. 2003 Jan;6(1):43-50. (PMID: 12469126)
J Neuropathol Exp Neurol. 2013 Jun;72(6):462-71. (PMID: 23656989)
J Alzheimers Dis. 2018;66(3):1131-1144. (PMID: 30400090)
Glia. 2018 Mar;66(3):637-653. (PMID: 29178139)
Front Cell Neurosci. 2022 Jun 16;16:899251. (PMID: 35783099)
PLoS One. 2013 May 20;8(5):e63644. (PMID: 23700429)
Front Mol Neurosci. 2017 Oct 16;10:331. (PMID: 29085281)
Nat Commun. 2020 Nov 30;11(1):6129. (PMID: 33257666)
Neurobiol Dis. 2021 Jan;148:105198. (PMID: 33242587)
Acta Neuropathol Commun. 2021 Sep 9;9(1):150. (PMID: 34503586)
Sci Rep. 2014 Dec 08;4:7362. (PMID: 25482017)
Alzheimers Res Ther. 2019 Nov 28;11(1):93. (PMID: 31779690)
J Alzheimers Dis. 2020;76(4):1179-1198. (PMID: 32597813)
J Neurosci. 2008 Aug 13;28(33):8150-60. (PMID: 18701677)
Cell Rep. 2020 Jun 30;31(13):107843. (PMID: 32610143)
J Hirnforsch. 1997;38(2):173-86. (PMID: 9176730)
Adv Neurobiol. 2021;26:21-53. (PMID: 34888829)
Acta Neuropathol Commun. 2021 Jan 5;9(1):1. (PMID: 33402227)
Mech Ageing Dev. 1985 Jun;31(1):25-35. (PMID: 2993763)
Front Mol Neurosci. 2018 Feb 08;11:13. (PMID: 29472840)
Metabolism. 2022 Apr;129:155142. (PMID: 35066003)
Glia. 2010 May;58(7):831-8. (PMID: 20140958)
Brain Sci. 2018 Aug 03;8(8):. (PMID: 30081456)
Brain Inj. 1998 May;12(5):409-27; discussion 407. (PMID: 9591144)
Invest Ophthalmol Vis Sci. 1977 Jun;16(6):582-5. (PMID: 405347)
J Neuroinflammation. 2022 Sep 27;19(1):235. (PMID: 36167544)
Prog Neurobiol. 2001 Aug;64(6):575-611. (PMID: 11311463)
Acta Neuropathol. 2021 May;141(5):681-696. (PMID: 33609158)
J Neurosci. 1999 Jun 1;19(11):4200-10. (PMID: 10341224)
J Neuroinflammation. 2019 Apr 16;16(1):87. (PMID: 30992040)
Prog Neurobiol. 2022 Jun;213:102264. (PMID: 35283239)
Brain Struct Funct. 2019 Apr;224(3):1301-1314. (PMID: 30706162)
Neuroscience. 2018 Aug 10;385:227-236. (PMID: 29932983)
Prog Neurobiol. 2019 Dec;183:101696. (PMID: 31550514)
Mol Neurodegener. 2019 Aug 2;14(1):32. (PMID: 31375134)
Front Mol Neurosci. 2018 Apr 06;11:100. (PMID: 29681795)
Genome Med. 2015 Oct 20;7:106. (PMID: 26482651)
BMC Neurosci. 2018 Oct 17;19(1):62. (PMID: 30333009)
Front Cell Neurosci. 2022 Feb 10;16:802411. (PMID: 35221920)
Cell. 2015 Jan 15;160(1-2):177-90. (PMID: 25594180)
Nat Neurosci. 2020 Jun;23(6):701-706. (PMID: 32341542)
Lancet Neurol. 2017 Nov;16(11):862-864. (PMID: 29029840)
Glia. 2014 Sep;62(9):1377-91. (PMID: 24807023)
J Biol Chem. 2018 May 11;293(19):7089-7098. (PMID: 29483195)
Glia. 2007 Sep;55(12):1214-1221. (PMID: 17659528)
Cell Metab. 2017 Nov 7;26(5):719-737.e6. (PMID: 28965825)
Grant Information:
FDN341846 CIHR Foundation grant
Contributed Indexing:
Keywords: APP-PS1 mice; Aging; Alzheimer’s disease; Astrocytes; Dark astrocytes; Heterogeneity; Human post-mortem brain samples; Ultrastructure
Substance Nomenclature:
0 (Amyloid beta-Protein Precursor)
0 (Presenilin-1)
Entry Date(s):
Date Created: 20230315 Date Completed: 20230316 Latest Revision: 20230317
Update Code:
20240104
PubMed Central ID:
PMC10015698
DOI:
10.1186/s12974-023-02752-7
PMID:
36918925
Czasopismo naukowe
The past decade has witnessed increasing evidence for a crucial role played by glial cells, notably astrocytes, in Alzheimer's disease (AD). To provide novel insights into the roles of astrocytes in the pathophysiology of AD, we performed a quantitative ultrastructural characterization of their intracellular contents and parenchymal interactions in an aged mouse model of AD pathology, as aging is considered the main risk factor for developing AD. We compared 20-month-old APP-PS1 and age-matched C57BL/6J male mice, among the ventral hippocampus CA1 strata lacunosum-moleculare and radiatum, two hippocampal layers severely affected by AD pathology. Astrocytes in both layers interacted more with synaptic elements and displayed more ultrastructural markers of increased phagolysosomal activity in APP-PS1 versus C57BL6/J mice. In addition, we investigated the ultrastructural heterogeneity of astrocytes, describing in the two examined layers a dark astrocytic state that we characterized in terms of distribution, interactions with AD hallmarks, and intracellular contents. This electron-dense astrocytic state, termed dark astrocytes, was observed throughout the hippocampal parenchyma, closely associated with the vasculature, and possessed several ultrastructural markers of cellular stress. A case study exploring the hippocampal head of an aged human post-mortem brain sample also revealed the presence of a similar electron-dense, dark astrocytic state. Overall, our study provides the first ultrastructural quantitative analysis of astrocytes among the hippocampus in aged AD pathology, as well as a thorough characterization of a dark astrocytic state conserved from mouse to human.
(© 2023. The Author(s).)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies